20 May 2013
Keywords: biogen, idec, seeks, pd, treatment, ngr1, biotechnology
Article | 05 December 2005
US biotechnology firm Biogen Idec says that it has discovered a new receptor that might be involved in the progression ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 December 2005
16 January 2006
17 May 2013
© 2013 thepharmaletter.com